0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Mefenamic Acid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-24B8059
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mefenamic Acid Market Insights Forecast to 2028
BUY CHAPTERS

Mefenamic Acid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24B8059
Report
November 2024
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mefenamic Acid - Market Size

The global market for Mefenamic Acid was estimated to be worth US$ 1935 million in 2023 and is forecast to a readjusted size of US$ 2628 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Mefenamic Acid - Market

Mefenamic Acid - Market

Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs, and is used to treat mild to moderate pain, including menstrual pain, and is sometimes used to prevent migraines associated with menstruation
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mefenamic Acid, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mefenamic Acid by region & country, by Type, and by Application.
The Mefenamic Acid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mefenamic Acid.
Market Segmentation

Scope of Mefenamic Acid - Market Report

Report Metric Details
Report Name Mefenamic Acid - Market
Forecasted market size in 2030 US$ 2628 million
CAGR 4.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Patent
  • Generic
Segment by Application
  • Hospital
  • Drug Store
  • On-line
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas, ABL Lifecare, Farmo Quimica, Apotex, Sanofi Aventis, Yung Sine, Streuli Pharma,, Mankind, Pfizer, Daiichi Sankyo, Chemidex Pharma, AA Pharma, Nisshin Pharmaceutical, Koa Isei, Teva, Wockhardt, Esteve
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Mefenamic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Mefenamic Acid in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Mefenamic Acid - Market size in 2030?

Ans: The Mefenamic Acid - Market size in 2030 will be US$ 2628 million.

Who are the main players in the Mefenamic Acid - Market report?

Ans: The main players in the Mefenamic Acid - Market are Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas, ABL Lifecare, Farmo Quimica, Apotex, Sanofi Aventis, Yung Sine, Streuli Pharma,, Mankind, Pfizer, Daiichi Sankyo, Chemidex Pharma, AA Pharma, Nisshin Pharmaceutical, Koa Isei, Teva, Wockhardt, Esteve

What are the Application segmentation covered in the Mefenamic Acid - Market report?

Ans: The Applications covered in the Mefenamic Acid - Market report are Hospital, Drug Store, On-line

What are the Type segmentation covered in the Mefenamic Acid - Market report?

Ans: The Types covered in the Mefenamic Acid - Market report are Patent, Generic

1 Market Overview
1.1 Mefenamic Acid Product Introduction
1.2 Global Mefenamic Acid Market Size Forecast
1.2.1 Global Mefenamic Acid Sales Value (2019-2030)
1.2.2 Global Mefenamic Acid Sales Volume (2019-2030)
1.2.3 Global Mefenamic Acid Sales Price (2019-2030)
1.3 Mefenamic Acid Market Trends & Drivers
1.3.1 Mefenamic Acid Industry Trends
1.3.2 Mefenamic Acid Market Drivers & Opportunity
1.3.3 Mefenamic Acid Market Challenges
1.3.4 Mefenamic Acid Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mefenamic Acid Players Revenue Ranking (2023)
2.2 Global Mefenamic Acid Revenue by Company (2019-2024)
2.3 Global Mefenamic Acid Players Sales Volume Ranking (2023)
2.4 Global Mefenamic Acid Sales Volume by Company Players (2019-2024)
2.5 Global Mefenamic Acid Average Price by Company (2019-2024)
2.6 Key Manufacturers Mefenamic Acid Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Mefenamic Acid Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mefenamic Acid
2.9 Mefenamic Acid Market Competitive Analysis
2.9.1 Mefenamic Acid Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Mefenamic Acid Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefenamic Acid as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Patent
3.1.2 Generic
3.2 Global Mefenamic Acid Sales Value by Type
3.2.1 Global Mefenamic Acid Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mefenamic Acid Sales Value, by Type (2019-2030)
3.2.3 Global Mefenamic Acid Sales Value, by Type (%) (2019-2030)
3.3 Global Mefenamic Acid Sales Volume by Type
3.3.1 Global Mefenamic Acid Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Mefenamic Acid Sales Volume, by Type (2019-2030)
3.3.3 Global Mefenamic Acid Sales Volume, by Type (%) (2019-2030)
3.4 Global Mefenamic Acid Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 On-line
4.2 Global Mefenamic Acid Sales Value by Application
4.2.1 Global Mefenamic Acid Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mefenamic Acid Sales Value, by Application (2019-2030)
4.2.3 Global Mefenamic Acid Sales Value, by Application (%) (2019-2030)
4.3 Global Mefenamic Acid Sales Volume by Application
4.3.1 Global Mefenamic Acid Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Mefenamic Acid Sales Volume, by Application (2019-2030)
4.3.3 Global Mefenamic Acid Sales Volume, by Application (%) (2019-2030)
4.4 Global Mefenamic Acid Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Mefenamic Acid Sales Value by Region
5.1.1 Global Mefenamic Acid Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mefenamic Acid Sales Value by Region (2019-2024)
5.1.3 Global Mefenamic Acid Sales Value by Region (2025-2030)
5.1.4 Global Mefenamic Acid Sales Value by Region (%), (2019-2030)
5.2 Global Mefenamic Acid Sales Volume by Region
5.2.1 Global Mefenamic Acid Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Mefenamic Acid Sales Volume by Region (2019-2024)
5.2.3 Global Mefenamic Acid Sales Volume by Region (2025-2030)
5.2.4 Global Mefenamic Acid Sales Volume by Region (%), (2019-2030)
5.3 Global Mefenamic Acid Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Mefenamic Acid Sales Value, 2019-2030
5.4.2 North America Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Mefenamic Acid Sales Value, 2019-2030
5.5.2 Europe Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Mefenamic Acid Sales Value, 2019-2030
5.6.2 Asia Pacific Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Mefenamic Acid Sales Value, 2019-2030
5.7.2 South America Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mefenamic Acid Sales Value, 2019-2030
5.8.2 Middle East & Africa Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mefenamic Acid Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mefenamic Acid Sales Value
6.2.1 Key Countries/Regions Mefenamic Acid Sales Value, 2019-2030
6.2.2 Key Countries/Regions Mefenamic Acid Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Mefenamic Acid Sales Value, 2019-2030
6.3.2 United States Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mefenamic Acid Sales Value, 2019-2030
6.4.2 Europe Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mefenamic Acid Sales Value, 2019-2030
6.5.2 China Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mefenamic Acid Sales Value, 2019-2030
6.6.2 Japan Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mefenamic Acid Sales Value, 2019-2030
6.7.2 South Korea Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mefenamic Acid Sales Value, 2019-2030
6.8.2 Southeast Asia Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mefenamic Acid Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mefenamic Acid Sales Value, 2019-2030
6.9.2 India Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mefenamic Acid Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Shionogi Pharma
7.1.1 Shionogi Pharma Company Information
7.1.2 Shionogi Pharma Introduction and Business Overview
7.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Shionogi Pharma Mefenamic Acid Product Offerings
7.1.5 Shionogi Pharma Recent Development
7.2 Solitaire Pharmacia
7.2.1 Solitaire Pharmacia Company Information
7.2.2 Solitaire Pharmacia Introduction and Business Overview
7.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Solitaire Pharmacia Mefenamic Acid Product Offerings
7.2.5 Solitaire Pharmacia Recent Development
7.3 Shinto Organics
7.3.1 Shinto Organics Company Information
7.3.2 Shinto Organics Introduction and Business Overview
7.3.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shinto Organics Mefenamic Acid Product Offerings
7.3.5 Shinto Organics Recent Development
7.4 Captab
7.4.1 Captab Company Information
7.4.2 Captab Introduction and Business Overview
7.4.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Captab Mefenamic Acid Product Offerings
7.4.5 Captab Recent Development
7.5 EMS Pharma
7.5.1 EMS Pharma Company Information
7.5.2 EMS Pharma Introduction and Business Overview
7.5.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.5.4 EMS Pharma Mefenamic Acid Product Offerings
7.5.5 EMS Pharma Recent Development
7.6 Adelco
7.6.1 Adelco Company Information
7.6.2 Adelco Introduction and Business Overview
7.6.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Adelco Mefenamic Acid Product Offerings
7.6.5 Adelco Recent Development
7.7 Agron Remedies
7.7.1 Agron Remedies Company Information
7.7.2 Agron Remedies Introduction and Business Overview
7.7.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Agron Remedies Mefenamic Acid Product Offerings
7.7.5 Agron Remedies Recent Development
7.8 IASIS Pharmaceuticals Hellas
7.8.1 IASIS Pharmaceuticals Hellas Company Information
7.8.2 IASIS Pharmaceuticals Hellas Introduction and Business Overview
7.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.8.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Offerings
7.8.5 IASIS Pharmaceuticals Hellas Recent Development
7.9 ABL Lifecare
7.9.1 ABL Lifecare Company Information
7.9.2 ABL Lifecare Introduction and Business Overview
7.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ABL Lifecare Mefenamic Acid Product Offerings
7.9.5 ABL Lifecare Recent Development
7.10 Farmo Quimica
7.10.1 Farmo Quimica Company Information
7.10.2 Farmo Quimica Introduction and Business Overview
7.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Farmo Quimica Mefenamic Acid Product Offerings
7.10.5 Farmo Quimica Recent Development
7.11 Apotex
7.11.1 Apotex Company Information
7.11.2 Apotex Introduction and Business Overview
7.11.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Apotex Mefenamic Acid Product Offerings
7.11.5 Apotex Recent Development
7.12 Sanofi Aventis
7.12.1 Sanofi Aventis Company Information
7.12.2 Sanofi Aventis Introduction and Business Overview
7.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sanofi Aventis Mefenamic Acid Product Offerings
7.12.5 Sanofi Aventis Recent Development
7.13 Yung Sine
7.13.1 Yung Sine Company Information
7.13.2 Yung Sine Introduction and Business Overview
7.13.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Yung Sine Mefenamic Acid Product Offerings
7.13.5 Yung Sine Recent Development
7.14 Streuli Pharma,
7.14.1 Streuli Pharma, Company Information
7.14.2 Streuli Pharma, Introduction and Business Overview
7.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Streuli Pharma, Mefenamic Acid Product Offerings
7.14.5 Streuli Pharma, Recent Development
7.15 Mankind
7.15.1 Mankind Company Information
7.15.2 Mankind Introduction and Business Overview
7.15.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Mankind Mefenamic Acid Product Offerings
7.15.5 Mankind Recent Development
7.16 Pfizer
7.16.1 Pfizer Company Information
7.16.2 Pfizer Introduction and Business Overview
7.16.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Pfizer Mefenamic Acid Product Offerings
7.16.5 Pfizer Recent Development
7.17 Daiichi Sankyo
7.17.1 Daiichi Sankyo Company Information
7.17.2 Daiichi Sankyo Introduction and Business Overview
7.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Daiichi Sankyo Mefenamic Acid Product Offerings
7.17.5 Daiichi Sankyo Recent Development
7.18 Chemidex Pharma
7.18.1 Chemidex Pharma Company Information
7.18.2 Chemidex Pharma Introduction and Business Overview
7.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Chemidex Pharma Mefenamic Acid Product Offerings
7.18.5 Chemidex Pharma Recent Development
7.19 AA Pharma
7.19.1 AA Pharma Company Information
7.19.2 AA Pharma Introduction and Business Overview
7.19.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.19.4 AA Pharma Mefenamic Acid Product Offerings
7.19.5 AA Pharma Recent Development
7.20 Nisshin Pharmaceutical
7.20.1 Nisshin Pharmaceutical Company Information
7.20.2 Nisshin Pharmaceutical Introduction and Business Overview
7.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Nisshin Pharmaceutical Mefenamic Acid Product Offerings
7.20.5 Nisshin Pharmaceutical Recent Development
7.21 Koa Isei
7.21.1 Koa Isei Company Information
7.21.2 Koa Isei Introduction and Business Overview
7.21.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Koa Isei Mefenamic Acid Product Offerings
7.21.5 Koa Isei Recent Development
7.22 Teva
7.22.1 Teva Company Information
7.22.2 Teva Introduction and Business Overview
7.22.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Teva Mefenamic Acid Product Offerings
7.22.5 Teva Recent Development
7.23 Wockhardt
7.23.1 Wockhardt Company Information
7.23.2 Wockhardt Introduction and Business Overview
7.23.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Wockhardt Mefenamic Acid Product Offerings
7.23.5 Wockhardt Recent Development
7.24 Esteve
7.24.1 Esteve Company Information
7.24.2 Esteve Introduction and Business Overview
7.24.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Esteve Mefenamic Acid Product Offerings
7.24.5 Esteve Recent Development
8 Industry Chain Analysis
8.1 Mefenamic Acid Industrial Chain
8.2 Mefenamic Acid Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mefenamic Acid Sales Model
8.5.2 Sales Channel
8.5.3 Mefenamic Acid Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Mefenamic Acid Market Trends
    Table 2. Mefenamic Acid Market Drivers & Opportunity
    Table 3. Mefenamic Acid Market Challenges
    Table 4. Mefenamic Acid Market Restraints
    Table 5. Global Mefenamic Acid Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mefenamic Acid Revenue Market Share by Company (2019-2024)
    Table 7. Global Mefenamic Acid Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Mefenamic Acid Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Mefenamic Acid Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Mefenamic Acid Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Mefenamic Acid Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Mefenamic Acid
    Table 13. Global Mefenamic Acid Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefenamic Acid as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Mefenamic Acid Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Mefenamic Acid Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Mefenamic Acid Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Mefenamic Acid Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Mefenamic Acid Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Mefenamic Acid Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Mefenamic Acid Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Mefenamic Acid Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Mefenamic Acid Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Mefenamic Acid Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Mefenamic Acid Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Mefenamic Acid Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Mefenamic Acid Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Mefenamic Acid Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Mefenamic Acid Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Mefenamic Acid Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Mefenamic Acid Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Mefenamic Acid Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Mefenamic Acid Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Mefenamic Acid Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Mefenamic Acid Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Mefenamic Acid Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Mefenamic Acid Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Mefenamic Acid Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Mefenamic Acid Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Mefenamic Acid Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Mefenamic Acid Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Mefenamic Acid Sales Value by Region (2019-2024) & (%)
    Table 44. Global Mefenamic Acid Sales Value by Region (2025-2030) & (%)
    Table 45. Global Mefenamic Acid Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Mefenamic Acid Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Mefenamic Acid Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Mefenamic Acid Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Mefenamic Acid Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Mefenamic Acid Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Mefenamic Acid Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Mefenamic Acid Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Mefenamic Acid Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Mefenamic Acid Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Mefenamic Acid Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Mefenamic Acid Sales Volume, (2025-2030) & (K Units)
    Table 57. Shionogi Pharma Company Information
    Table 58. Shionogi Pharma Introduction and Business Overview
    Table 59. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Shionogi Pharma Mefenamic Acid Product Offerings
    Table 61. Shionogi Pharma Recent Development
    Table 62. Solitaire Pharmacia Company Information
    Table 63. Solitaire Pharmacia Introduction and Business Overview
    Table 64. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Solitaire Pharmacia Mefenamic Acid Product Offerings
    Table 66. Solitaire Pharmacia Recent Development
    Table 67. Shinto Organics Company Information
    Table 68. Shinto Organics Introduction and Business Overview
    Table 69. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Shinto Organics Mefenamic Acid Product Offerings
    Table 71. Shinto Organics Recent Development
    Table 72. Captab Company Information
    Table 73. Captab Introduction and Business Overview
    Table 74. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Captab Mefenamic Acid Product Offerings
    Table 76. Captab Recent Development
    Table 77. EMS Pharma Company Information
    Table 78. EMS Pharma Introduction and Business Overview
    Table 79. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. EMS Pharma Mefenamic Acid Product Offerings
    Table 81. EMS Pharma Recent Development
    Table 82. Adelco Company Information
    Table 83. Adelco Introduction and Business Overview
    Table 84. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Adelco Mefenamic Acid Product Offerings
    Table 86. Adelco Recent Development
    Table 87. Agron Remedies Company Information
    Table 88. Agron Remedies Introduction and Business Overview
    Table 89. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Agron Remedies Mefenamic Acid Product Offerings
    Table 91. Agron Remedies Recent Development
    Table 92. IASIS Pharmaceuticals Hellas Company Information
    Table 93. IASIS Pharmaceuticals Hellas Introduction and Business Overview
    Table 94. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Offerings
    Table 96. IASIS Pharmaceuticals Hellas Recent Development
    Table 97. ABL Lifecare Company Information
    Table 98. ABL Lifecare Introduction and Business Overview
    Table 99. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. ABL Lifecare Mefenamic Acid Product Offerings
    Table 101. ABL Lifecare Recent Development
    Table 102. Farmo Quimica Company Information
    Table 103. Farmo Quimica Introduction and Business Overview
    Table 104. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Farmo Quimica Mefenamic Acid Product Offerings
    Table 106. Farmo Quimica Recent Development
    Table 107. Apotex Company Information
    Table 108. Apotex Introduction and Business Overview
    Table 109. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Apotex Mefenamic Acid Product Offerings
    Table 111. Apotex Recent Development
    Table 112. Sanofi Aventis Company Information
    Table 113. Sanofi Aventis Introduction and Business Overview
    Table 114. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Sanofi Aventis Mefenamic Acid Product Offerings
    Table 116. Sanofi Aventis Recent Development
    Table 117. Yung Sine Company Information
    Table 118. Yung Sine Introduction and Business Overview
    Table 119. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Yung Sine Mefenamic Acid Product Offerings
    Table 121. Yung Sine Recent Development
    Table 122. Streuli Pharma, Company Information
    Table 123. Streuli Pharma, Introduction and Business Overview
    Table 124. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Streuli Pharma, Mefenamic Acid Product Offerings
    Table 126. Streuli Pharma, Recent Development
    Table 127. Mankind Company Information
    Table 128. Mankind Introduction and Business Overview
    Table 129. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Mankind Mefenamic Acid Product Offerings
    Table 131. Mankind Recent Development
    Table 132. Pfizer Company Information
    Table 133. Pfizer Introduction and Business Overview
    Table 134. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Pfizer Mefenamic Acid Product Offerings
    Table 136. Pfizer Recent Development
    Table 137. Daiichi Sankyo Company Information
    Table 138. Daiichi Sankyo Introduction and Business Overview
    Table 139. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Daiichi Sankyo Mefenamic Acid Product Offerings
    Table 141. Daiichi Sankyo Recent Development
    Table 142. Chemidex Pharma Company Information
    Table 143. Chemidex Pharma Introduction and Business Overview
    Table 144. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Chemidex Pharma Mefenamic Acid Product Offerings
    Table 146. Chemidex Pharma Recent Development
    Table 147. AA Pharma Company Information
    Table 148. AA Pharma Introduction and Business Overview
    Table 149. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. AA Pharma Mefenamic Acid Product Offerings
    Table 151. AA Pharma Recent Development
    Table 152. Nisshin Pharmaceutical Company Information
    Table 153. Nisshin Pharmaceutical Introduction and Business Overview
    Table 154. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Nisshin Pharmaceutical Mefenamic Acid Product Offerings
    Table 156. Nisshin Pharmaceutical Recent Development
    Table 157. Koa Isei Company Information
    Table 158. Koa Isei Introduction and Business Overview
    Table 159. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Koa Isei Mefenamic Acid Product Offerings
    Table 161. Koa Isei Recent Development
    Table 162. Teva Company Information
    Table 163. Teva Introduction and Business Overview
    Table 164. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Teva Mefenamic Acid Product Offerings
    Table 166. Teva Recent Development
    Table 167. Wockhardt Company Information
    Table 168. Wockhardt Introduction and Business Overview
    Table 169. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Wockhardt Mefenamic Acid Product Offerings
    Table 171. Wockhardt Recent Development
    Table 172. Esteve Company Information
    Table 173. Esteve Introduction and Business Overview
    Table 174. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Esteve Mefenamic Acid Product Offerings
    Table 176. Esteve Recent Development
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Mefenamic Acid Downstream Customers
    Table 180. Mefenamic Acid Distributors List
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mefenamic Acid Product Picture
    Figure 2. Global Mefenamic Acid Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Mefenamic Acid Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Mefenamic Acid Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Mefenamic Acid Report Years Considered
    Figure 7. Global Mefenamic Acid Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Mefenamic Acid Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mefenamic Acid Revenue in 2023
    Figure 10. Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Patent Picture
    Figure 12. Generic Picture
    Figure 13. Global Mefenamic Acid Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Mefenamic Acid Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Mefenamic Acid Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Mefenamic Acid Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Mefenamic Acid Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drug Store
    Figure 20. Product Picture of On-line
    Figure 21. Global Mefenamic Acid Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Mefenamic Acid Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Mefenamic Acid Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Mefenamic Acid Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Mefenamic Acid Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Mefenamic Acid Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Mefenamic Acid Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Mefenamic Acid Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Mefenamic Acid Sales Volume (%), (2019-2030)
    Figure 38. United States Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Mefenamic Acid Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Mefenamic Acid Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Mefenamic Acid Sales Value by Application (%), 2023 VS 2030
    Figure 59. Mefenamic Acid Industrial Chain
    Figure 60. Mefenamic Acid Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS